Number of Hours of Sleep and Risk of Stroke

Sleep duration (either short or long) affect the risk of stroke according to this recent analysis. We had visited a study published in JACC on the link between acute MI and sleep duration. This study appears to show similar results as regards sleep duration and stroke. 

Cantidad de horas de sueño y riesgo de stroke

The work prospectively included 79,881 men and women between 45 and 79 followed up until their first event (event or stroke) for mean 14.6 years. The study also looked into genetic polymorphisms identified with sleep duration obtained from a publicly available database (MEGASTROKE and the International Stroke Genetics Consortia).

Long sleep (>9 hours a day) was associated with increased total risk of stroke and ischemic stroke (HR 1.12 and 1.14, respectively), while short sleep (<7 hours a day) increased the risk of intracranial bleeding. 

These results replicate almost exactly the MI results, where sleeping over 9 hours a day or fewer than 6 hours a day increases MI risk by 20 to 30%.


Read also: Hours of Sleep and Myocardial Infarction Risk.


The genetic analysis was not that clear, opening the possibility of a casual association. Without question, we do not have enough information to recommend a number of hours of sleep a day as primary prevention strategy against MI or stroke.

Conclusion

This large prospective study associated long sleep with increased risk of total and ischemic stroke, while short sleep was associated to intracranial bleeding. 

Original Title: Sleep Duration and Stroke. Prospective Cohort Study and Mendelian Randomization Analysis.

Reference: Olga E. Titova et al. Stroke. 2020 Nov;51(11):3279-3285. doi: 10.1161/STROKEAHA.120.029902.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

ACC 2026 | SirPAD Trial: Sirolimus-coated balloon angioplasty in infrainguinal arterial disease

Paclitaxel-coated balloons have demonstrated improved patency in peripheral arterial disease (PAD), although questions remain regarding safety and applicability across different vascular territories. In this...

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...